Boehringer earns NICE nod for IPF drug Ofev
September 14, 2015Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis
NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …
The making of a modern pharma blockbuster
September 11, 2015Medical Communications Big Pharma, Twice Circled, computer game
The pharma industry divides opinions on its morality, but what has always stood out is the fact that in this …
US FDA accepts first digital medicine application
September 11, 2015Medical Communications FDA, NDA, Otsuka, digital, digital medicine, proteus
The FDA has accepted the first New Drug Application for a digital medicine: Otsuka and Proteus Digital Health’s collaboration of …
Supply chain leaders call for forward pharma thinking
September 11, 2015Manufacturing and Production, Medical Communications fly pharma, fly pharma conference, logistics, supply chain
Logistics companies must improve their understanding of the pharma industry to better serve their customers, according to a supply chain …
Envision Pharma acquires two medical education specialists in takeover deal
September 11, 2015Medical Communications
Two principals from Alligent Biopharm Consulting have joined the UK communications group Envision Pharma following an acquisition deal.Alligent’s two principals, …
Medimmune and Cancer Research UK launch new drug discovery lab
September 11, 2015Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman
MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …
Pfizer in metabolic disease push
September 11, 2015Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity
Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions. …
Actelion confirms takeover talks with ZS Pharma
September 11, 2015Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions
Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
High Court rules against Pfizer in Lyrica patent case
September 10, 2015Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin
The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
EM Imaging appoints new chairman
September 10, 2015Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology
The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020
September 10, 2015Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones
The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …
Lung cancer market to hit $10.9bn by 2021
September 10, 2015Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer
The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
Mylan to relaunch $27.1bn hostile takeover of Perrigo
September 10, 2015Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover
Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
Gilead’s Truvada prevents HIV infections in high-risk men
September 10, 2015Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections
UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
GSK begins work on £100m India facility
September 9, 2015Manufacturing and Production GlaxoSmithKline, India, manufacturing
GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …
Pharma leaders urge UK Government not to cut spending
September 9, 2015Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding
Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
Neurimmune kicks off late-stage Alzheimer’s study
September 9, 2015Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology
Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab. The …
GSK suffers Breo late-stage trial blow
September 9, 2015Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III
GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …
Mission Therapeutics appoints new chief medical officer
September 9, 2015Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics
Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …
Yabao Pharmaceutical and UniSA embark on joint venture
September 9, 2015Research and Development Cancer, Yabao Pharmaceutical
Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
